Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 35% ± 17% | |
lung | 10 studies | 22% ± 7% | |
peripheral blood | 7 studies | 26% ± 11% | |
eye | 5 studies | 23% ± 6% | |
intestine | 4 studies | 21% ± 7% | |
bone marrow | 4 studies | 27% ± 12% | |
heart | 4 studies | 20% ± 4% | |
liver | 4 studies | 34% ± 14% | |
adipose | 4 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6560.37 | 1445 / 1445 | 100% | 44.51 | 183 / 183 |
ovary | 100% | 7656.35 | 180 / 180 | 100% | 37.15 | 429 / 430 |
intestine | 100% | 7178.87 | 966 / 966 | 100% | 24.71 | 525 / 527 |
prostate | 100% | 6358.94 | 245 / 245 | 100% | 31.23 | 500 / 502 |
bladder | 100% | 7121.38 | 21 / 21 | 99% | 24.01 | 501 / 504 |
breast | 100% | 6941.96 | 459 / 459 | 99% | 36.92 | 1111 / 1118 |
thymus | 100% | 9413.85 | 653 / 653 | 99% | 31.63 | 600 / 605 |
brain | 99% | 4349.81 | 2627 / 2642 | 100% | 29.59 | 703 / 705 |
lung | 100% | 7071.83 | 578 / 578 | 99% | 30.46 | 1145 / 1155 |
stomach | 100% | 6001.33 | 359 / 359 | 99% | 28.83 | 283 / 286 |
skin | 100% | 7244.32 | 1809 / 1809 | 99% | 27.95 | 466 / 472 |
pancreas | 100% | 3884.65 | 328 / 328 | 98% | 20.66 | 175 / 178 |
uterus | 100% | 7635.86 | 170 / 170 | 98% | 28.06 | 450 / 459 |
kidney | 100% | 4350.45 | 89 / 89 | 95% | 16.35 | 853 / 901 |
adrenal gland | 100% | 6264.26 | 258 / 258 | 84% | 11.81 | 193 / 230 |
liver | 100% | 3477.72 | 226 / 226 | 81% | 10.09 | 328 / 406 |
adipose | 100% | 6384.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6476.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.65 | 29 / 29 |
muscle | 100% | 4769.46 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9884.09 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.78 | 1 / 1 |
heart | 99% | 4045.82 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 14.13 | 76 / 80 |
peripheral blood | 94% | 5799.61 | 876 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030071 | Biological process | regulation of mitotic metaphase/anaphase transition |
GO_0045582 | Biological process | positive regulation of T cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0045663 | Biological process | positive regulation of myoblast differentiation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0042921 | Biological process | nuclear receptor-mediated glucocorticoid signaling pathway |
GO_0070316 | Biological process | regulation of G0 to G1 transition |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_2000819 | Biological process | regulation of nucleotide-excision repair |
GO_0006337 | Biological process | nucleosome disassembly |
GO_0030521 | Biological process | androgen receptor signaling pathway |
GO_2000781 | Biological process | positive regulation of double-strand break repair |
GO_0030520 | Biological process | estrogen receptor signaling pathway |
GO_0007399 | Biological process | nervous system development |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0071565 | Cellular component | nBAF complex |
GO_0071564 | Cellular component | npBAF complex |
GO_0016514 | Cellular component | SWI/SNF complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0035060 | Cellular component | brahma complex |
GO_0000785 | Cellular component | chromatin |
GO_0140092 | Cellular component | bBAF complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0031491 | Molecular function | nucleosome binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ARID1A |
Protein name | AT-rich interaction domain 1A AT-rich interactive domain-containing protein 1A ARID1A variant protein AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD) ARID1A protein ARID1A |
Synonyms | C1orf4 SMARCF1 protein BAF250 variant OSA1 BAF250A |
Description | FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Binds DNA non-specifically. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). . |
Accessions | A0A1B0GVT5 H0YEW5 ENST00000430799.7 ENST00000374152.7 [O14497-3] E9PQW6 H0Y488 Q4LE49 ENST00000324856.13 [O14497-1] A4FU79 ENST00000457599.6 [O14497-2] ENST00000532781.1 ENST00000637465.1 H0YCU6 A0A0S2Q0B1 ENST00000524572.1 ENST00000466382.2 A0A1B0GTU5 C1KEN7 ENST00000636219.1 O14497 |